4//SEC Filing
Lutz Robert Matthew 4
Accession 0001179110-21-002120
CIK 0001634432other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:16 PM ET
Size
4.7 KB
Accession
0001179110-21-002120
Insider Transaction Report
Form 4
Lutz Robert Matthew
Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2021-02-22$3.62/sh−6,978$25,260→ 181,333 total
Footnotes (1)
- [F1]Shares withheld by Strongbridge Biopharma plc to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.
Documents
Issuer
Strongbridge Biopharma plc
CIK 0001634432
Entity typeother
Related Parties
1- filerCIK 0001786203
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:16 PM ET
- Size
- 4.7 KB